Evidence map›Paper›PMID 31464559›Full record

ArticleJournal of aerosol medicine and pulmonary drug delivery2020

Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

Dale Farkas, Michael Hindle, Serena Bonasera, Karl Bass, Worth Longest

Open access · greenAbstract read
In one paragraph

Article in Journal of aerosol medicine and pulmonary drug delivery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dale FarkasDepartment of Mechanical and Nuclear Engineering and Virginia Commonwealth University, Richmond, Virginia.
Michael HindleDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia.
Serena BonaseraDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia.
Karl BassDepartment of Mechanical and Nuclear Engineering and Virginia Commonwealth University, Richmond, Virginia.
Worth LongestDepartment of Mechanical and Nuclear Engineering and Virginia Commonwealth University, Richmond, Virginia.
Virginia Commonwealth University · US

Funding

High Efficiency Delivery of Surfactant Aerosols to Infants without IntubationR01HL139673 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HINDLE, MICHAEL, LONGEST, P. WORTH · 2018 to 2021
$2.8M
High Efficiency Inhalation Delivery of Tobramycin for Children with Cystic FibrosisR01HD087339 · NICHD · VIRGINIA COMMONWEALTH UNIVERSITY · PI HINDLE, MICHAEL, LONGEST, P. WORTH · 2017 to 2021
$2.5M
NHLBI NIH HHS R01 HL139673NICHD NIH HHS R01 HD087339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Delivery SystemsDry Powder InhalersAdministration, IntranasalAdministration, OralAerosolsChild, PreschoolEquipment DesignExcipientsHumansLungParticle SizeTissue DistributionAerosolsExcipients3D printingactive DPIaerosol delivery to childreninline DPIin vitro testingspray-dried powder

Identifiers

PMID31464559
PMCPMC7133455
OpenAlexW2971089700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.